MEP moves to increase information to patients on prescription drugsBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c1368 (Published 08 March 2010) Cite this as: BMJ 2010;340:c1368
- Rory Watson
A Swedish member of the European parliament, Christofer Fjellner, has acknowledged that he will be challenging many medical professionals in steering draft legislation through the parliament that would allow pharmaceutical companies to give more information to patients about prescription drugs.
The MEP, a Christian Democrat, has assessed the European Commission’s legislative proposal, and he will present his assessment to the European parliament’s environment committee before the end of the month. Speaking after a workshop in Brussels on 4 March on the subject, he set out his approach.
He said, “It is clear there are big cultural differences in Europe …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial